ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: net current accounts receivable
Net current accounts receivable for ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED financial histories
What this measure means
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
Exact concept: us-gaap:AccountsReceivableNetCurrent. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2019-03-31 to 2024-03-31. The SEC response was captured on 2026-09-21.
This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2024-03-31 | 790,626 | USD | 2024-11-07 | 20-F · 0001079973-24-001482 |
| At date | 2023-03-31 | 353,703 | USD | 2024-11-07 | 20-F · 0001079973-24-001482 |
| At date | 2022-03-31 | 194,138 | USD | 2024-11-07 | 20-F · 0001079973-24-001482 |
| At date | 2021-03-31 | 264,749 | USD | 2024-11-07 | 20-F · 0001079973-24-001482 |
| At date | 2020-03-31 | 329,891 | USD | 2021-08-16 | 20-F · 0001079973-21-000792 |
| At date | 2019-03-31 | 363,491 | USD | 2020-08-17 | 20-F · 0001079973-20-000706 |
Related financial histories
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: total assets
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: total liabilities
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: stockholders equity
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: net income or loss
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: operating cash flow
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: capital expenditure payments
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: revenue
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: financing cash flow
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: investing cash flow
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: retained earnings or deficit
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: basic weighted-average shares
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: diluted weighted-average shares
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: basic earnings per share
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: diluted earnings per share
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: income tax expense or benefit
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: net property, plant and equipment
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: share-based compensation expense
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: operating income or loss
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: current assets
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: interest expense
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: current liabilities
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: operating expenses
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: net inventory
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: gross profit
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: cost of revenue
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: research and development expense
Inspect the source
- Entity
- ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED / CIK 0001672886
- Captured
- 2026-09-21T17:22:51.018Z
- SEC response SHA-256
5779345d654e0c5bdccd0db49d6a4f5f72a8525c49074d7feb9e4523f0bd33c1
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001672886.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))